Procalcitonin used as a marker of infection in the intensive care unit

被引:312
作者
Ugarte, H
Silva, E
Mercan, D
De Mendonça, A
Vincent, JL
机构
[1] Free Univ Brussels, Hop Erasme, Dept Intens Care, B-1070 Brussels, Belgium
[2] Free Univ Brussels, Hop Erasme, Dept Clin Chem, B-1070 Brussels, Belgium
关键词
C-reactive protein; inflammatory response; fever; white blood cell count; diagnosis; prognosis; sepsis; septic shock; survival;
D O I
10.1097/00003246-199903000-00024
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine the Value of procalcitonin (ProCT) as a marker of infection in critically ill patients. Design: Prospective, observational study. Setting: Medicosurgical department of intensive care(31 beds). Patients: One hundred eleven infected and 79 noninfected patients. interventions: None. Measurements and Main Results: ProCT and C-reactive protein (CRP) concentrations were monitored daily. The best cutoff values for ProCT and CRP were 0.6 ng/mL and 7.9 mg/dL, respectively. Compared with CRP, ProCT had a lower sensitivity(67.6 vs. 71.8), specificity (61.3 vs. 66.6), and area under the receiver operating characteristic curve (0.66 vs. 0.78, p < .05). The combination of ProCT and CRP increased the specificity far infection to 82.3%. In the infected patients, plasma ProCT, but not CRP, Values were higher in nonsurvivors than in survivors. Infected patients with bacteremia had higher ProCT concentrations than those without bacteremia, but similar CRP concentrations. ProCT levels were particularly high in septic shock patients. Conclusions: ProCT is not a better marker of infection than CRP in critically ill patients, but it can represent a useful adjunctive parameter to identify infection and is a useful marker of the severity of infection.
引用
收藏
页码:498 / 504
页数:7
相关论文
共 26 条
  • [1] Al-Nawas B, 1996, Eur J Med Res, V1, P331
  • [2] HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION
    ASSICOT, M
    GENDREL, D
    CARSIN, H
    RAYMOND, J
    GUILBAUD, J
    BOHUON, C
    [J]. LANCET, 1993, 341 (8844) : 515 - 518
  • [3] BECK JR, 1986, ARCH PATHOL LAB MED, V110, P13
  • [4] BERGER C, 1995, EUR J PEDIATR, V154, P138
  • [5] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [6] BRUNKHORST FM, 1996, INTENS CARE MED, V22, pS338
  • [7] BRUNKHORST FM, 1995, INTENSIVE CARE ME S1, V21, pS12
  • [8] PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS
    DANDONA, P
    NIX, D
    WILSON, MF
    ALJADA, A
    LOVE, J
    ASSICOT, M
    BOHUON, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) : 1605 - 1608
  • [9] ENGELMANN L, 1996, INTENSIVE CARE ME S3, V22, pS333
  • [10] INTERLEUKIN-6 AND ACUTE-PHASE PROTEIN CONCENTRATIONS IN SURGICAL INTENSIVE-CARE UNIT PATIENTS - DIAGNOSTIC SIGNS IN NOSOCOMIAL INFECTION
    FASSBENDER, K
    PARGGER, H
    MULLER, W
    ZIMMERLI, W
    [J]. CRITICAL CARE MEDICINE, 1993, 21 (08) : 1175 - 1180